kh607
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 21, 2023 (NCT06393803)
Timeline
Indications
Mechanism of action
- LHFPL tetraspan subfamily member 4 proteinALLOSTERIC ANTAGONIST
LHFPL4 allosteric antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07101120 | Phase 2 | Aug 31, 2025 | Chengdu Kanghong Biotech Co.,Ltd. |
| NCT07096791 | Phase 2 | Jul 31, 2025 | Chengdu Kanghong Biotech Co.,Ltd. |
| NCT06393803 | Phase 1 | Oct 21, 2023 | Chengdu Kanghong Biotech Co.,Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chengdu Kanghong Biotech Co.,Ltd. | For profit | 3 | 3 | 2 | 2023 |
1 organizations
Page 1 / 1